Latest filing published 03 Jun 2022 for Arcutis Biotherapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +85.4%Entry US$1.99 · Close at T+365 US$3.69
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph L. Turner: trading record in brief
Joseph L. Turner (board member) discloses dealings in 6 companies, chiefly Myogen Inc, Corcept Therapeutics Inc and Kythera Biopharmaceuticals Inc. Between 4 January 2006 and 1 June 2022, the trades on record add up to 45 filings.
Market trades split into 2 purchases (€15k) and 17 sales (€2.4M). Taken together, the sales exceed the purchases by €2.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 18 option exercises.
The latest filing, published on 3 June 2022, reports a share grant in Arcutis Biotherapeutics, Inc. The clock since the last published purchase (14 March 2013) now reads 4,987 days. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph L. Turner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,312 shares0Common StockSEC:0001567619-22-012310:0
- 1,050 sharesCommon StockSEC:0001209191-16-129011:0
- 1,872 sharesCommon StockSEC:0001104659-15-068859:0
- 1,500 shares@ US$2.00Common stockSEC:0001209191-13-016611:0Canonical exit: 11 Jun 2013 (T+90)
- 8,500 shares@ US$2.01Common stockSEC:0001209191-13-016611:1Canonical exit: 12 Jun 2013 (T+90)
- 1,872 sharesCommon StockSEC:0001104659-12-069364:0
- 55,000 shares@ US$1.82Common StockSEC:0001127602-12-025804:0
- 2,571 sharesCommon StockSEC:0001209191-06-060977:0
- 73,532 sharesCommon StockSEC:0001209191-06-060107:0
- 3,000 shares@ US$2.50Common StockSEC:0001209191-06-059331:0
- 29,948 shares@ US$1.25Common StockSEC:0001209191-06-059331:1
- 33,919 shares@ US$5.00Common StockSEC:0001209191-06-059331:2
- 5,000 shares@ US$1.25Common StockSEC:0001209191-06-050352:0
- 5,000 shares@ US$34.88Common StockSEC:0001209191-06-050352:1
- 2,500 shares@ US$33.05Common StockSEC:0001209191-06-047034:0
- 5,000 shares@ US$1.25Common StockSEC:0001209191-06-046263:0
- 5,000 shares@ US$30.67Common StockSEC:0001209191-06-046263:1
- 2,500 shares@ US$28.50Common StockSEC:0001209191-06-042016:0
- 5,000 shares@ US$1.25Common StockSEC:0001209191-06-041529:0
- 5,000 shares@ US$26.85Common StockSEC:0001209191-06-041529:1
- 2,500 shares@ US$28.41Common StockSEC:0001209191-06-037631:0
- 5,000 shares@ US$1.25Common StockSEC:0001209191-06-037359:0
- 5,000 shares@ US$29.74Common StockSEC:0001209191-06-037359:1
- 5,000 shares@ US$1.25Common StockSEC:0001209191-06-030483:0
- 5,000 shares@ US$31.34Common StockSEC:0001209191-06-030483:1
25 of 44 declarations
